Two Sigma Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,026,567
Closed -$6.17M 2856
2022
Q4
$6.17M Buy
1,026,567
+82,454
+9% +$496K 0.02% 697
2022
Q3
$5.5M Sell
944,113
-57,000
-6% -$332K 0.02% 690
2022
Q2
$5.98M Buy
1,001,113
+57,700
+6% +$344K 0.02% 693
2022
Q1
$4.41M Buy
943,413
+385,300
+69% +$1.8M 0.01% 848
2021
Q4
$1.38M Sell
558,113
-523,500
-48% -$1.3M ﹤0.01% 1378
2021
Q3
$3.19M Sell
1,081,613
-90,600
-8% -$267K 0.01% 1004
2021
Q2
$2.93M Buy
1,172,213
+652,000
+125% +$1.63M 0.01% 1114
2021
Q1
$1.51M Buy
520,213
+408,600
+366% +$1.19M ﹤0.01% 1411
2020
Q4
$359K Sell
111,613
-110,370
-50% -$355K ﹤0.01% 1989
2020
Q3
$477K Buy
221,983
+130,100
+142% +$280K ﹤0.01% 1846
2020
Q2
$107K Sell
91,883
-1,000
-1% -$1.17K ﹤0.01% 2352
2020
Q1
$85K Sell
92,883
-800
-0.9% -$732 ﹤0.01% 2319
2019
Q4
$148K Sell
93,683
-18,900
-17% -$29.9K ﹤0.01% 2226
2019
Q3
$94K Sell
112,583
-600
-0.5% -$501 ﹤0.01% 2116
2019
Q2
$97K Sell
113,183
-1,300
-1% -$1.11K ﹤0.01% 2216
2019
Q1
$111K Sell
114,483
-1,000
-0.9% -$970 ﹤0.01% 2183
2018
Q4
$85K Buy
115,483
+14,200
+14% +$10.5K ﹤0.01% 2235
2018
Q3
$219K Buy
101,283
+4,400
+5% +$9.51K ﹤0.01% 2060
2018
Q2
$482K Buy
+96,883
New +$482K ﹤0.01% 1937
2016
Q2
Sell
-1,120
Closed -$6K 2319
2016
Q1
$6K Buy
+1,120
New +$6K ﹤0.01% 2017
2013
Q3
Sell
-6,223
Closed -$65K 2004
2013
Q2
$65K Buy
+6,223
New +$65K ﹤0.01% 1531